KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Receivables - Other: 2011-2013

Historic Receivables - Other for Biocryst Pharmaceuticals (BCRX) over the last 2 years, with Sep 2013 value amounting to $2.4 million.

  • Biocryst Pharmaceuticals' Receivables - Other fell 37.13% to $2.4 million in Q3 2013 from the same period last year, while for Sep 2013 it was $2.4 million, marking a year-over-year decrease of 37.13%. This contributed to the annual value of $4.6 million for FY2012, which is 21.76% down from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Receivables - Other stood at $2.4 million for Q3 2013, which was up 131.35% from $1.0 million recorded in Q2 2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Receivables - Other ranged from a high of $5.8 million in Q4 2011 and a low of $1.0 million during Q2 2013.
  • Its 3-year average for Receivables - Other is $3.9 million, with a median of $4.3 million in 2013.
  • Data for Biocryst Pharmaceuticals' Receivables - Other shows a maximum YoY tumbled of 79.86% (in 2013) over the last 5 years.
  • Biocryst Pharmaceuticals' Receivables - Other (Quarterly) stood at $5.8 million in 2011, then fell by 21.76% to $4.6 million in 2012, then tumbled by 37.13% to $2.4 million in 2013.
  • Its Receivables - Other was $2.4 million in Q3 2013, compared to $1.0 million in Q2 2013 and $4.3 million in Q1 2013.